| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 02/02/2012 | US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds) |
| 02/02/2012 | US20120030778 Genomic editing of genes involved with parkinsons disease |
| 02/02/2012 | US20120030776 Novel gene disruptions, compositions and methods relating thereto |
| 02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
| 02/02/2012 | US20120027689 Methods and compositions for altering photophysical properites of fluorophores via proximal quenching |
| 02/02/2012 | US20120027688 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 02/02/2012 | US20120027687 Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke |
| 02/02/2012 | US20120027686 Hk1-binding proteins |
| 02/02/2012 | US20120027685 Determining the capability of a test compound to affect solid tumor stem cells |
| 02/02/2012 | US20120027684 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
| 02/02/2012 | US20120027683 Diabetes t cell receptors |
| 02/02/2012 | US20120027682 Pyrazine Derivatives for Optical Imaging and Therapy |
| 02/02/2012 | US20120027681 Low-Aspect Ratio Carbon Nanostructures |
| 02/02/2012 | US20120027680 Oxime conjugates and methods for their formation and use |
| 02/02/2012 | US20120027679 Contrast agent for photoacoustic imaging and photoacoustic imaging method using the same |
| 02/02/2012 | US20120027678 Method of using stem cells to aid in diagnosis |
| 02/02/2012 | US20120027677 Prion-specific peptoid reagents |
| 02/02/2012 | US20120027676 Modified sodium iodide symporter proteins and uses thereof |
| 02/02/2012 | US20120027675 Targeting pulmonary epithelium using adrp |
| 02/02/2012 | CA2806679A1 An antigen specific ultrasound contrast medium, a process for the preparation thereof and its uses |
| 02/01/2012 | EP2411052A2 Carrier comprising a vitamin e derivative |
| 02/01/2012 | EP2411022A1 Compositions for bowel preparation and methods of use thereof |
| 02/01/2012 | EP2410907A2 Site localization and methods for monitoring treatment of disturbed blood vessels |
| 02/01/2012 | EP1615544B1 Arrangement and method for the spatially resolved determination of state variables in an examination area |
| 02/01/2012 | EP1590005B1 Conjugates of enantiomer-pure (4s,8s)- and (4r,8r)-4-p-benzyl-8-methyl-3,6,9-triaza- sp 3 /sp n, sp 6 /sp n, sp 9 /sp n-tricarboxymethyl-1,11-undecanoic acid with biomolecules, method for the production thereof and their use for producing pharmaceutical agents |
| 02/01/2012 | CN102341126A Gadolinium expressed lipid nanoparticles for magnetic resonance imaging |
| 02/01/2012 | CN102336838A Paramagnetic metal complex and synthetic method and application thereof |
| 02/01/2012 | CN102336681A Triiodobenzene compound contrast agent |
| 02/01/2012 | CN102335441A Method and gel composition to prevent reflection of hifu at tissue-air interface |
| 02/01/2012 | CN101897669B 一种脑靶向递药系统 Kind of brain-targeted drug delivery systems |
| 01/31/2012 | US8106027 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8106026 Development of a preventive vaccine for filovirus infection in primates |
| 01/31/2012 | US8105567 Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 01/31/2012 | US8104433 Long-lasting gustatory and/or olfactory aversion veterinary compositions for behavior modification |
| 01/31/2012 | CA2558233C Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 01/26/2012 | WO2012011794A1 Large animal model for evaluating the effectiveness of antivenoms in blood |
| 01/26/2012 | WO2011122770A3 Magnetic resonance imaging contrast agent coated with polymer having mannose-modified terminal, and preparation method thereof |
| 01/26/2012 | US20120021450 Methods for magnetic resonance imaging |
| 01/26/2012 | US20120020894 Production of Targeted MRI Probes by Biocompatible Coupling of Macromolecules with Charged Nanoparticles |
| 01/26/2012 | US20120020893 Intravascular Imaging Device and Uses Thereof |
| 01/26/2012 | US20120020892 Force-induced magnetization contrast for diagnosis and imaging |
| 01/26/2012 | US20120020891 Metabolites for oral health and uses thereof |
| 01/26/2012 | US20120020890 Staphylococcus aureus proteins and nucleic acids |
| 01/26/2012 | US20120020889 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin |
| 01/26/2012 | US20120020888 Biomarker |
| 01/26/2012 | US20120020887 Use of Simple Amino Acids to Form Porous Particles |
| 01/26/2012 | US20120020886 Thermal spin cross-over compounds and methods of using same |
| 01/26/2012 | US20120020885 MHC-Less cells |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | US20120020878 Fusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems |
| 01/26/2012 | US20120020876 Hedgehog pathway inhibitors |
| 01/25/2012 | EP2410334A1 T-lymphocyte mitogen for use in a skin test |
| 01/25/2012 | EP2409715A1 Models for vaccine assessment |
| 01/25/2012 | EP2409714A1 Models for vaccine assessment |
| 01/25/2012 | EP2408755A2 Psma-targeting compounds and uses thereof |
| 01/25/2012 | EP2408481A2 Magnetic resonance imaging contrast agent with paramagnetic-inositol phosphates complexes |
| 01/25/2012 | EP1746928B1 Optical sensor for in vivo detection of analyte |
| 01/25/2012 | CN1374870B Treatment of intermediate-and high-grade non-Hodgkins lymphoma with anti-CD20 antibody |
| 01/25/2012 | CN102333547A Nanoparticle contrast agents for diagnostic imaging |
| 01/25/2012 | CN102329775A Gemcitabine-tolerant human pancreatic cancer cell line and application thereof |
| 01/25/2012 | CN102329438A Magnetic chitosan/doped rare earth compound particles and preparation method thereof |
| 01/25/2012 | CN102329374A Gastric-cancer targeted peptide and application thereof |
| 01/25/2012 | CN102327625A Water-soluble nano composite material and preparation method and use thereof |
| 01/25/2012 | CN102038964B Amorphous Fe-Co-B nano magnetic resonance contrast agent material and preparation method thereof |
| 01/25/2012 | CN101926821B Drug composition for targeted release of trace elements and preparation method and application thereof |
| 01/25/2012 | CN101797391B Disposable bactericidal medical ultrasonic couplant and preparation method thereof |
| 01/25/2012 | CN101785759B Nanoparticle for embedding medicinal Adriamycin as well as preparation method and application thereof |
| 01/25/2012 | CN101745124B Gadolinium-containing silicon dioxide nanosphere magnetic resonance contrast agent and preparation method thereof |
| 01/25/2012 | CN101444630B Method for preparing high magnetic resonance sensitivity ferroferric oxide nano-particle with tumor-targeting function |
| 01/24/2012 | US8101718 Methods of administering porcine B-domainless fVIII |
| 01/24/2012 | US8101181 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 01/24/2012 | US8101159 In vivo methods of identifying compounds which target suppressed cancer cells |
| 01/24/2012 | US8101158 Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity |
| 01/24/2012 | US8101157 Targeting ligands for radiation guided delivery of an actice agent that bind to a TIP-1 polypeptide |
| 01/24/2012 | CA2456055C Microoroganisms and cells for diagnosis and therapy of tumors |
| 01/24/2012 | CA2427726C Methods and devices for polarised nmr samples |
| 01/19/2012 | WO2012007886A1 Lipid bilayer carrier for drugs or imaging agents |
| 01/19/2012 | WO2012007567A1 Nanoparticle-guided radiotherapy |
| 01/19/2012 | WO2012007456A1 X-ray imaging at low contrast agent concentrations and/or low dose radiation |
| 01/19/2012 | WO2012006938A1 Pharmaceutical composition capable of targeted release of trace element, and preparation method and application of pharmaceutical composition |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011116341A3 Longevity of hyperpolarized enhanced signals for nmr spectroscopy |
| 01/19/2012 | WO2011112970A3 Compositions and methods for bioconjugation to quantum dots |
| 01/19/2012 | WO2011106309A3 Materials and methods for mri contrast agents and drug delivery |
| 01/19/2012 | WO2011102626A3 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
| 01/19/2012 | US20120015878 Use of adnf polypeptides for treating anxiety and depression |
| 01/19/2012 | US20120014975 Modified single domain antigen binding molecules and uses thereof |
| 01/19/2012 | US20120014881 Methods for detecting a mycobacterium tuberculosis infection |
| 01/19/2012 | US20120014880 METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING alpha1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS |
| 01/19/2012 | US20120014879 USE OF TUMOR NECROSIS FACTOR-alpha RECEPTOR p75 FOR TREATMENT OF ISCHEMIA-INDUCED NEOVASCULARIZATION |
| 01/19/2012 | US20120014878 Synthesis of Oligonucleotide Mediated Gold Core- Silver Shell Nanoparticles |
| 01/19/2012 | US20120014877 COMPOSITIONS AND METHODS TO TREAT CANCER WITH CpG RICH DNA AND CUPREDOXINS |
| 01/19/2012 | US20120014876 Antagonistic peptides for frizzled-1 and frizzled-2 |
| 01/19/2012 | US20120014875 Nucleic acid aptamers |
| 01/19/2012 | US20120014874 Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | US20120014872 Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers |
| 01/19/2012 | US20120014868 Methods to diagnose degenerative disc disease |
| 01/19/2012 | CA2804849A1 Nanoparticle-guided radiotherapy |
| 01/19/2012 | CA2801828A1 X-ray imaging at low contrast agent concentrations and/or low dose radiation |